AZD-8359

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameAZD-8359
Drug Alias NameAZD8359AZD-8359
ClassificationBiologics > T cell engagersBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionSix-transmembrane epithelial antigen of the prostate 2 modulators
TargetsSix-transmembrane epithelial antigen of the prostate 2
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A